For any of you that don’t subscribe to the daily “Smart Brief” that the Food & Drug Law Institute puts out – and if you’re interested in drug and device law, you should (it’s free) – we’d just like to note the story indicating that the Senate “companion bill” to the anti-preemption legislation in the House that we’ve already mentioned was introduced today.

Here’s a link directly to the FDA News story about the Senate-side bill, since FDA News, unlike Smart Brief, doesn’t require a subscription.